Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>On Feb. 18, Pfizer and BioNTech announced they would dose about 4,000 healthy pregnant women with the COVID-19 vaccine to evaluate its safety, tolerability, and immunogenicity.&nbsp;Although pregnant people were excluded initially from the COVD-19 trials, research has shown they are at higher risk for more severe disease.</p>

Study of COVID-19 Vaccine in Pregnant People ‘Too Late’

Financial and public relations risks are obstacles to their inclusion